JILL BARNHOLTZ-SLOAN, PH.D.

Associate Director for Clinical Informatics

Dr. Jill Barnholtz-Sloan, Ph.D., is the Sally S. Morley Designated Professor in Brain Tumor Research in the Case Comprehensive Cancer Center.  Her research focuses on genetic/molecular epidemiology of complex diseases, with a particular focus on cancer.  She is multi-disciplinary trained in biostatistics, population genetics, and human genetics, and has rich experience in multi-center cancer studies.  The main thrust of her research is two-fold: (1) as an integral biostatistical/epidemiological co-investigator on multiple externally funded studies (i.e. “team science”) and (2) as an independent brain tumor researcher and collaborator.  She is the Associate Director for Bioinformatics for the Case Comprehensive Cancer Center and the Associate Director for Clinical Informatics for the Institute for Computational Biology. 

In her role as a team scientist, Dr. Barnholtz-Sloan is sought for her biostatistical/bioinformatics expertise and collaborate on studies as the expert in these disciplines.  She assists investigators with robust study design, data analysis and interpretation of results.  At the core of her independent research efforts is her work on utilizing genomic information on brain tumors to better sub-classify these tumors and associate this information with clinical outcomes.  Because brain tumors are a rare cancer (representing only 1-2% of all adult cancers), multi-center projects are necessary in order to have the samples size needed for appropriate statistical power.  Since coming to CWRU, she has successfully established a multi-center biorepository network within Ohio, the Ohio Brain Tumor Study (OBTS), which has served as a multi-site tissue source site for The Cancer Genome Atlas and currently serves as a multi-site therapeutic clinical trial network for the Governor’s Ohio Clinical Trials Collaborative. 

Affiliations

CWRUlogowTag240x120CC-logoUH_cancer

Featured Publications

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, […]

Alex’s Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS,. The CBTRUS Statistical Report: Alex’s Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011 comprehensively describes the current population-based incidence of […]

The somatic genomic landscape of glioblastoma.

Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, […]

Recent Publications

  1. Cummings, LC, Thota, PN, Willis, JE, Chen, Y, Cooper, GS, Furey, N, Bednarchik, B, Alashkar, BM, Dumot, J, Faulx, AL et al.. A nonrandomized trial of vitamin D supplementation for Barrett's esophagus. PLoS ONE 2017; 12 (9): e0184928. PubMed PMID:28922414 .
  2. Seth, D, Gittleman, H, Barnholtz-Sloan, J, Bordeaux, JS. Association of Socioeconomic and Geographic Factors With Google Trends for Tanning and Sunscreen. Dermatol Surg 2017; : . PubMed PMID:28902024 .
  3. McNamara, C, Abbott, SE, Bandera, EV, Qin, B, Peres, LC, Camacho, F, Moorman, PG, Alberg, AJ, Barnholtz-Sloan, JS, Bondy, M et al.. Tubal ligation and ovarian cancer risk in African American women. Cancer Causes Control 2017; : . PubMed PMID:28871344 .
  4. Khanna, V, Achey, RL, Ostrom, QT, Block-Beach, H, Kruchko, C, Barnholtz-Sloan, JS, de Blank, PM. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013. J. Neurooncol. 2017; : . PubMed PMID:28828582 .
  5. Wilson, RT, Masters, LD, Barnholtz-Sloan, JS, Salzberg, AC, Hartman, TJ. Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association with Cytochrome 3A (CYP3A) Polymorphisms. Am. J. Epidemiol. 2017; : . PubMed PMID:28673024 .
  6. Gittleman, H, Cote, DJ, Ostrom, QT, Kruchko, C, Smith, TR, Claus, EB, Barnholtz-Sloan, JS. Do race and age vary in non-malignant central nervous system tumor incidences in the United States? J. Neurooncol. 2017; : . PubMed PMID:28667594 .
  7. Molitoris, JK, Rao, YJ, Patel, RA, Kane, LT, Badiyan, SN, Gittleman, H, Barnholtz-Sloan, JS, Bentzen, SM, Kruser, TJ, Huang, J et al.. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation. J. Neurooncol. 2017; : . PubMed PMID:28643151 .
  8. de Blank, P, Fisher, MJ, Gittleman, H, Barnholtz-Sloan, JS, Badve, C, Berman, JI. Validation of an automated tractography method for the optic radiations as a biomarker of visual acuity in neurofibromatosis-associated optic pathway glioma. Exp. Neurol. 2017; : . PubMed PMID:28587872 .
  9. Kromer, C, Xu, J, Ostrom, QT, Gittleman, H, Kruchko, C, Sawaya, R, Barnholtz-Sloan, JS. Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study. J. Neurooncol. 2017; 134 (1): 55-64. PubMed PMID:28567587 .
  10. Soler, DC, Young, AB, Cooper, KD, Kerstetter-Fogle, A, Barnholtz-Sloan, JS, Gittleman, H, McCormick, TS, Sloan, AE. The ratio of HLA-DR and VNN2(+) expression on CD14(+) myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients. J. Neurooncol. 2017; 134 (1): 189-196. PubMed PMID:28551851 .
Search PubMed